TELETRADER News
10/23, 8:31 PM (Source: TeleTrader)
more TeleTrader news

AstraZeneca allowed to continue vaccine trial in US - report

The study of the COVID-19 vaccine developed by AstraZeneca Plc and Oxford University has been allowed to resume in the United States, a report by The Wall Street Journal unveiled on Friday, citing a person familiar with the mater and materials that the outlet reviewed.

The US Food and Drug Administration (FDA) has finished the assessment of the two participants who have potentially developed neurological side effects from the jab and has given the pharmaceutical company permission to go on with the late-stage trial, the report added.

The vaccine study has been halted in early September but has restarted in the United Kingdom four days later. Earlier this week, a report by Politico hinted that AstraZeneca is in talks with the FDA, noting, at that time, that the agency might allow the British firm to resume the trial soon.

Breaking the News / BU